Immunogenicity and Safety of Three Consecutive Lots of a New Inactivated Enterovirus Type 71 (EV71) Vaccine: A Double-blind, Randomized and Controlled Trial

Trial Profile

Immunogenicity and Safety of Three Consecutive Lots of a New Inactivated Enterovirus Type 71 (EV71) Vaccine: A Double-blind, Randomized and Controlled Trial

Completed
Phase of Trial: Phase III

Latest Information Update: 26 Feb 2014

At a glance

  • Drugs Enterovirus A vaccine (Primary)
  • Indications Coxsackievirus infections; Enterovirus A infections
  • Focus Pharmacodynamics; Registrational
  • Sponsors Sinovac Biotech
  • Most Recent Events

    • 26 Feb 2014 Results have been published online in the October 2013 issue of the Clinical and Vaccine Immunology according to a Sinovac Biotech media release.
    • 14 Mar 2013 Results published in a Sinovac Biotech media release.
    • 01 Mar 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top